According to Alembic Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 0,42ย โฌ. In 2018 the company made an earnings per share (EPS) of 0,38ย โฌ an increase over its 2017 EPS that were of 0,31ย โฌ.